Browse by Section 100 Item List

Highly Specialised Drugs Program (Community Access)

From 1 July 2015, the HSD community access arrangements better align existing HSD programme arrangements with current clinical practice and models of care, through improvements to the way clozapine for the treatment of schizophrenia (maintenance therapy only), HIV antiretroviral medicines and hepatitis B medicines are prescribed, dispensed and accessed under the s100 HSDs Programme.  These changes are known as ‘HSD Community Access’.

These arrangements remove the requirement for patients and prescribers to be affiliated with a hospital setting.  Patients also have greater choice about where they access their medicines, through either a community pharmacy, or a private or public hospital pharmacy.  Community pharmacists are able to dispense these medicines regardless of where the medicine is prescribed.

Prescriptions for these medicines and any repeats from those prescriptions, written prior to 1 July 2015 will need to be dispensed by a hospital pharmacy in accordance with the previous arrangements.

The remuneration rates for Highly Specialised Drugs dispensed through community pharmacies are aligned to those paid to private hospitals.

Patient eligibility criteria are unchanged.  Patients will continue to pay a patient co-payment which will contribute to the PBS Safety Net Record.

Further information on these arrangements is available in the respective Frequently Asked Questions (FAQs).

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
  • SO
    Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
    Supply Only
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 10287K DARUNAVIRdarunavir 150 mg tablet, 240 1 240 5
MPNP 10329P DARUNAVIRdarunavir 600 mg tablet, 60 2 120 5
MPNP 10367P DARUNAVIRdarunavir 800 mg tablet, 30 2 60 5
MPNP 10903W DARUNAVIR + COBICISTATdarunavir 800 mg + cobicistat 150 mg tablet, 30 2 60 5
MPNP 11955F DARUNAVIR + COBICISTAT + EMTRICITABINE + TENOFOVIR ALAFENAMIDEdarunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet, 30 2 60 5
MPNP 10283F DOLUTEGRAVIRdolutegravir 50 mg tablet, 30 2 60 5
MPNP 10345L DOLUTEGRAVIR + ABACAVIR + LAMIVUDINEdolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet, 30 2 60 5
MPNP 11843H DOLUTEGRAVIR + LAMIVUDINEdolutegravir 50 mg + lamivudine 300 mg tablet, 30 2 60 5
MPNP 11540J DOLUTEGRAVIR + RILPIVIRINEdolutegravir 50 mg + rilpivirine 25 mg tablet, 30 2 60 5